SiriusPoint 過去の業績
過去 基準チェック /56
SiriusPointは、平均年間21.9%の収益成長を遂げていますが、 Insurance業界の収益は、年間 成長しています。収益は、平均年間14.6% 11.2%収益成長率で 成長しています。 SiriusPointの自己資本利益率は21.7%であり、純利益率は16%です。
主要情報
21.91%
収益成長率
16.95%
EPS成長率
| Insurance 業界の成長 | 8.02% |
| 収益成長率 | 11.23% |
| 株主資本利益率 | 21.72% |
| ネット・マージン | 16.02% |
| 前回の決算情報 | 31 Mar 2026 |
最近の業績更新
Recent updates
Seeking Alpha • Jun 30
SiriusPoint: The Turnaround Is Over, But The Valuation Hasn't Caught Up
Summary SiriusPoint has evolved from a turnaround story into a disciplined specialty insurer with a significantly lower-risk underwriting profile. Continued reductions in catastrophe exposure are making earnings more durable rather than simply boosting one quarter's results. Capital allocation has shifted from balance sheet repair toward buybacks, preferred share redemptions, and long-term shareholder value creation. I upgrade SPNT to 'Strong BUY,' citing a significant earnings multiple discount, robust underwriting discipline, and durable returns now overlooked by the market. Read the full article on Seeking Alpha
ナラティブの更新 • Jun 29
SPNT: Resumed Buy Rating And Capital Returns Will Drive Bullish Repricing
Analysts have raised their SiriusPoint price target from $24 to $27, citing updated assumptions around discount rates, profit margins, and future P/E that they view as better aligned with the stock's current risk and earnings profile. What’s in the News for SiriusPoint SiriusPoint was removed from several Russell growth and small cap benchmarks, including the Russell 3000 Growth, Russell 2500 Growth, Russell 2000 Growth, Russell 3000E Growth, Russell Small Cap Comp Growth, and Russell 2000 Growth-Defensive Indexes.
ナラティブの更新 • Jun 15
SPNT: Buy Rating And Crisis Lines Expansion Will Shape Earnings And Margins
Analysts have adjusted their price target on SiriusPoint to $23.00, citing updated assumptions for revenue growth, profit margins, and future P/E that align with recent research coverage resuming on the stock. What's in the News SiriusPoint launched a new Crisis Solutions class of business within its London Market Specialty division, focused on building underwriting, exposure management, and claims capabilities in this area.ナラティブの更新 • Jun 01
SPNT: Reorganization And Buy Rating Will Shape Earnings And Margin Delivery
Narrative Update on SiriusPoint Analysts have kept their SiriusPoint price target steady at $23.00, with the unchanged fair value supported by expectations for revenue growth alongside slightly firmer profit margins and a modestly lower assumed future P/E multiple. Analyst Commentary Recent Street commentary on SiriusPoint has focused on how current expectations and the US$23.00 target line up with execution and valuation risks.ナラティブの更新 • May 04
SPNT: Reorganization And Buy Rating Will Test Execution And Earnings Resilience
Analysts have modestly raised their $23.00 price target on SiriusPoint, reflecting updated assumptions around revenue, profit margins, and future P/E. This revision is supported by renewed Buy-rated coverage from the Street.ナラティブの更新 • Apr 20
SPNT: Neutral Outlook Will Weigh Reorganization Benefits Against Execution And Earnings Risks
Analysts have adjusted their SiriusPoint price target to $23.00, with the change supported by updated assumptions around slightly higher revenue growth, an improved profit margin outlook, and a lower future P/E multiple. Analyst Commentary Recent Street research around SiriusPoint centers on whether the current share price already reflects the updated $23.00 target, especially given the revised assumptions on revenue, margins, and a lower future P/E multiple.ナラティブの更新 • Apr 03
SPNT: Neutral Outlook Will Balance Capital Moves With Execution And Earnings Risks
The analyst price target for SiriusPoint has increased from $22 to $23, with analysts citing revised assumptions around fair value, revenue growth, profit margin, and future P/E to support this change. Analyst Commentary Recent research coverage has taken a measured stance on SiriusPoint, with the new analysis tending to frame the current price target in the context of execution risk, valuation assumptions, and the durability of earnings.ナラティブの更新 • Mar 20
SPNT: Neutral Coverage And Capital Moves Will Set Up Bullish Repricing
Analysts trimmed their price target on SiriusPoint by $0.59 due to slightly lower profit margin assumptions and a higher future P/E multiple following recent neutral research coverage. Analyst Commentary Recent neutral research coverage frames SiriusPoint as fairly balanced at current levels, with the trimmed price target reflecting fine tuning of profit margin expectations and a higher assumed future P/E multiple rather than a major shift in the core thesis.ナラティブの更新 • Mar 06
SPNT: Neutral Rating And Share Actions Will Set Up Rerating Potential
Narrative Update on SiriusPoint Analysts have reset their price target on SiriusPoint from $27.50 to $24.00, citing revised assumptions around growth, profitability, discount rates and a higher future P/E multiple, alongside recent neutral research coverage. Analyst Commentary Recent research coverage on SiriusPoint has taken a neutral stance overall, focusing on how updated assumptions around growth, profitability and discount rates line up with the new US$24.00 price target.ナラティブの更新 • Feb 19
SPNT: Neutral Stance Will Weigh Capital Simplification Against Execution Risks
Analysts have maintained their $22.00 price target on SiriusPoint, citing updated assumptions for revenue growth, profit margins, and future P/E, along with the recent neutral initiation of coverage by Raymond James. Analyst Commentary Recent research commentary around SiriusPoint has leaned cautious, with the neutral initiation signaling that some analysts see a balance between potential upside and key execution risks.ナラティブの更新 • Feb 05
SPNT: Neutral Outlook Will Weigh Capital Simplification Against Execution Risks
Analysts have lifted their price target on SiriusPoint from US$21.00 to US$22.00, citing updated assumptions around revenue growth, profit margins, and future P/E as key drivers of the change. Analyst Commentary Recent Street research on SiriusPoint, including a neutral initiation, points to a more balanced view, where potential upside is weighed against clear execution and valuation risks.ナラティブの更新 • Oct 04
Rising Global Reinsurance Demand Will Unlock Specialty Potential
Analysts have raised their price target for SiriusPoint from $25.33 to $27.50. This reflects a more optimistic outlook based on slightly higher projected revenue growth and modest adjustments in key valuation metrics.分析記事 • Jul 24
Potential Upside For SiriusPoint Ltd. (NYSE:SPNT) Not Without Risk
With a price-to-earnings (or "P/E") ratio of 15.4x SiriusPoint Ltd. ( NYSE:SPNT ) may be sending bullish signals at the...新しいナラティブ • Jun 29
Refined Underwriting And Climate Reinsurance Will Unlock Opportunities
Enhanced specialty underwriting and analytics are driving sustainable earnings growth, increased profitability, and improved operating efficiency.分析記事 • May 14
We Think Shareholders Are Less Likely To Approve A Large Pay Rise For SiriusPoint Ltd.'s (NYSE:SPNT) CEO For Now
Key Insights SiriusPoint will host its Annual General Meeting on 20th of May CEO Scott Egan's total compensation...分析記事 • Mar 13
It's A Story Of Risk Vs Reward With SiriusPoint Ltd. (NYSE:SPNT)
With a price-to-earnings (or "P/E") ratio of 13.3x SiriusPoint Ltd. ( NYSE:SPNT ) may be sending bullish signals at the...分析記事 • Aug 26
Not Many Are Piling Into SiriusPoint Ltd. (NYSE:SPNT) Just Yet
There wouldn't be many who think SiriusPoint Ltd.'s ( NYSE:SPNT ) price-to-sales (or "P/S") ratio of 0.9x is worth a...分析記事 • May 08
Investors Holding Back On SiriusPoint Ltd. (NYSE:SPNT)
There wouldn't be many who think SiriusPoint Ltd.'s ( NYSE:SPNT ) price-to-sales (or "P/S") ratio of 0.8x is worth a...Seeking Alpha • Mar 06
Tracking Dan Loeb's Third Point Portfolio - Q4 2023 Update
Summary Dan Loeb's 13F portfolio value increased to $6.64B this quarter, with the top three holdings accounting for ~37% of the portfolio. Third Point returned 3.4% in 2023 compared to 26.3% for the S&P 500 Index. New stakes include Fleetcor Tech, Verizon, Apollo Global Management, McKesson Corp, EQT Corp, and Biomarin Pharma. Read the full article on Seeking Alpha分析記事 • Jan 23
SiriusPoint Ltd. (NYSE:SPNT) Could Be Riskier Than It Looks
With a median price-to-sales (or "P/S") ratio of close to 1x in the Insurance industry in the United States, you could...Seeking Alpha • Jan 22
Revisiting SiriusPoint Common And Preferred
Summary SiriusPoint's preferred units have shot up nicely in recent months, generating strong returns for shareholders. SPNT's financial health has improved, with increased profits and a decline in some activities. The common units are still rated a 'buy' due to increased profitability, but the limited upside that remains necessitates a downgrade for the preferred units. Read the full article on Seeking AlphaSeeking Alpha • Sep 25
SiriusPoint Offers Extremely Undervalued 9.3% Bond And An Excellent Preferred Stock
Summary We first revisit our recommendation of SiriusPoint preferred stock from May of this year. Although SPNT-B has been a big winner for us since May, it is still the most undervalued among “qualified” BB+ rated preferred stocks plus it has a massive reset rate. At the current 5-year treasury note yield, the reset yield on SPNT-B will be 12% and it trades below par. SiriusPoint also offers an extremely undervalued bond with an investment grade BBB rating and an approximate 9.3% yield-to-maturity (YTM). A typical BBB bond has a YTM of around 6.3% making this 9.3% YTM bond the most undervalued bond in the market based on credit rating (in my opinion). Read the full article on Seeking AlphaSeeking Alpha • Feb 23
SiriusPoint GAAP EPS of -$0.17, revenue of $673.6M
SiriusPoint press release (NYSE:SPNT): Q4 GAAP EPS of -$0.17. Revenue of $673.6M (+69.2% Y/Y). Combined ratio of 90.4%, underwriting income of $58M. Core income of $25M. Net investment income of $52M. Tangible book value per diluted common share decreased $0.15, or 1.4%, from September 30, 2022 to $10.43 per share. Annualized return on average common equity of (5.7)%.収支内訳
収支内訳
SiriusPoint の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。
収益と収入の歴史
| 日付 | 収益 | 収益 | G+A経費 | 研究開発費 |
|---|---|---|---|---|
| 31 Mar 26 | 3,030 | 485 | 268 | 0 |
| 31 Dec 25 | 2,983 | 443 | 257 | 0 |
| 30 Sep 25 | 2,859 | 186 | 252 | 0 |
| 30 Jun 25 | 2,794 | 106 | 241 | 0 |
| 31 Mar 25 | 2,682 | 149 | 237 | 0 |
| 31 Dec 24 | 2,656 | 176 | 232 | 0 |
| 30 Sep 24 | 2,674 | 281 | 232 | 0 |
| 30 Jun 24 | 2,697 | 330 | 239 | 0 |
| 31 Mar 24 | 2,820 | 277 | 231 | 0 |
| 31 Dec 23 | 2,795 | 315 | 258 | 0 |
| 30 Sep 23 | 2,810 | 201 | 234 | 0 |
| 30 Jun 23 | 2,704 | 49 | 242 | 0 |
| 31 Mar 23 | 2,418 | -64 | 242 | 0 |
| 31 Dec 22 | 2,078 | -403 | 313 | 0 |
| 30 Sep 22 | 1,830 | -506 | 265 | 0 |
| 30 Jun 22 | 1,963 | -456 | 260 | 0 |
| 31 Mar 22 | 2,049 | -333 | 253 | 0 |
| 31 Dec 21 | 2,130 | 41 | 267 | 0 |
| 30 Sep 21 | 2,119 | 305 | 140 | 0 |
| 30 Jun 21 | 1,652 | 421 | 95 | 0 |
| 31 Mar 21 | 1,362 | 484 | 51 | 0 |
| 31 Dec 20 | 890 | 142 | 42 | 0 |
| 30 Sep 20 | 751 | 39 | 43 | 0 |
| 30 Jun 20 | 689 | -45 | 37 | 0 |
| 31 Mar 20 | 636 | -116 | 48 | 0 |
| 31 Dec 19 | 983 | 200 | 36 | 0 |
| 30 Sep 19 | 656 | -128 | 49 | 0 |
| 30 Jun 19 | 582 | -126 | 49 | 0 |
| 31 Mar 19 | 540 | -159 | 39 | 0 |
| 31 Dec 18 | 377 | -318 | 36 | 0 |
| 30 Sep 18 | 639 | 25 | 43 | 0 |
| 30 Jun 18 | 699 | 93 | 47 | 0 |
| 31 Mar 18 | 807 | 147 | 52 | 0 |
| 31 Dec 17 | 933 | 278 | 53 | 0 |
| 30 Sep 17 | 894 | 187 | 44 | 0 |
| 30 Jun 17 | 924 | 204 | 43 | 0 |
| 31 Mar 17 | 862 | 183 | 39 | 0 |
| 31 Dec 16 | 692 | 28 | 39 | 0 |
| 30 Sep 16 | 729 | 116 | 44 | 0 |
| 30 Jun 16 | 528 | -151 | 42 | 0 |
| 31 Mar 16 | 463 | -189 | 46 | 0 |
| 31 Dec 15 | 574 | -87 | 46 | 0 |
| 30 Sep 15 | 559 | -144 | 46 | 0 |
質の高い収益: SPNTには$222.4M } という大きな 一回限りの 利益があり、過去 12 か月の財務実績が31st March, 2026に影響を及ぼしています。
利益率の向上: SPNTの現在の純利益率 (16%)は、昨年(5.6%)よりも高くなっています。
フリー・キャッシュフローと収益の比較
過去の収益成長分析
収益動向: SPNTの収益は過去 5 年間で年間21.9%増加しました。
成長の加速: SPNTの過去 1 年間の収益成長率 ( 225.7% ) は、5 年間の平均 ( 年間21.9%を上回っています。
収益対業界: SPNTの過去 1 年間の収益成長率 ( 225.7% ) はInsurance業界36.2%を上回りました。
株主資本利益率
高いROE: SPNTの 自己資本利益率 ( 21.7% ) は 高い とみなされます。
総資産利益率
使用総資本利益率
過去の好業績企業の発掘
企業分析と財務データの現状
| データ | 最終更新日（UTC時間） |
|---|---|
| 企業分析 | 2026/07/06 18:31 |
| 終値 | 2026/07/06 00:00 |
| 収益 | 2026/03/31 |
| 年間収益 | 2025/12/31 |
データソース
企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。
| パッケージ | データ | タイムフレーム | 米国ソース例 |
|---|---|---|---|
| 会社財務 | 10年 |
| |
| アナリストのコンセンサス予想 | +プラス3年 |
|
|
| 市場価格 | 30年 |
| |
| 所有権 | 10年 |
| |
| マネジメント | 10年 |
| |
| 主な進展 | 10年 |
|
* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。
特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。
分析モデルとスノーフレーク
このレポートを生成するために使用した分析モデルの詳細は、当社の Github ページ でご覧いただけます。また、レポートの使い方に関する ガイド や YouTube の チュートリアル もご用意しています。
シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。
業界およびセクターの指標
私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。
アナリスト筋
SiriusPoint Ltd. 4 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。7
| アナリスト | 機関 |
|---|---|
| Jay Cohen | BofA Global Research |
| Randy Binner | B. Riley Securities, Inc. |
| Timothy D'Agostino | B. Riley Securities, Inc. |